In a recent episode of the Health Care Network, Marshall Jackson breaks down what’s really driving the current wave of ...

London Managing Partner Aymen Mahmoud spoke with City AM about the growth of securities litigation in the United Kingdom as ...

On September 1, 2026, global law firm McDermott Will & Schulte filed an amicus curiae brief on behalf of the National ...

Advises fund managers on the structuring and formation of investment funds. Provides regulatory advice to fund and asset managers as well as institutional investors. Establishes and comprehensively ...

McDermott Will & Schulte is pleased to host Women in Security and Privacy (WISP) for an evening of networking at our Munich ...

Kate McDonald represents clients across the healthcare industry on complex regulatory matters and high-stakes mergers and acquisitions, affiliations and other investments. She delivers strategic ...

McDermott Will & Schulte announced that Julia Winters has joined the Firm as a partner in its Business Restructuring group in New York. Julia arrives from Katten and focuses on restructuring and ...

London Office Managing Partner and European Head of Finance Aymen Mahmoud and Partner Priya Taneja co-authored an IFLR article examining India’s growing appeal to private capital investors and the ...

In a recent Private Equity Law Report article, Dan Oshinsky discussed with PELR the growing use of LP portfolio financing facilities as investors seek alternative sources of liquidity amid a continued ...

Plan sponsors should update payroll and plan administration systems for the 2027 cost-of-living adjustments and incorporate the new limits in relevant participant communications, such as open ...

McDermott Will & Schulte served as legal counsel to Unitex Textile Services LLC (“Unitex”), a leading provider of outsourced healthcare textile management services, in its strategic partnership with ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for ...